Metropolitan Life Insurance Company (MetLife)’s Bruker BRKR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-22,960
| Closed | -$1.93M | – | 2305 |
|
|
2021
Q4 | $1.93M | Buy |
22,960
+16,100
| +235% | +$1.29M | 0.03% | 556 |
|
|
2021
Q3 | $536K | Sell |
6,860
-225
| -3% | -$18.7K | 0.01% | 1416 |
|
|
2021
Q2 | $538K | Buy |
7,085
+2,694
| +61% | +$188K | 0.01% | 1474 |
|
|
2021
Q1 | $282K | Sell |
4,391
-96
| -2% | -$5.77K | ﹤0.01% | 1783 |
|
|
2020
Q4 | $243K | Sell |
4,487
-102
| -2% | -$4.89K | ﹤0.01% | 1809 |
|
|
2020
Q3 | $182K | Sell |
4,589
-104
| -2% | -$4.34K | ﹤0.01% | 1832 |
|
|
2020
Q2 | $191K | Sell |
4,693
-2,466
| -34% | -$97.1K | ﹤0.01% | 1829 |
|
|
2020
Q1 | $257K | Sell |
7,159
-226
| -3% | -$10.5K | 0.01% | 1445 |
|
|
2019
Q4 | $376K | Sell |
7,385
-137
| -2% | -$6.52K | 0.01% | 1510 |
|
|
2019
Q3 | $330K | Buy |
7,522
+3,084
| +69% | +$138K | 0.01% | 1545 |
|
|
2019
Q2 | $222K | Sell |
4,438
-69
| -2% | -$2.91K | ﹤0.01% | 1835 |
|
|
2019
Q1 | $173K | Sell |
4,507
-88
| -2% | -$3.18K | ﹤0.01% | 1991 |
|
|
2018
Q4 | $137K | Buy |
4,595
+1
| +0% | +$32 | ﹤0.01% | 2072 |
|
|
2018
Q3 | $154K | Sell |
4,594
-210
| -4% | -$6.92K | ﹤0.01% | 2191 |
|
|
2018
Q2 | $140K | Buy |
4,804
+174
| +4% | +$5.29K | ﹤0.01% | 2149 |
|
|
2018
Q1 | $139K | Buy |
4,630
+5
| +0.1% | +$162 | ﹤0.01% | 2117 |
|
|
2017
Q4 | $159K | Sell |
4,625
-231
| -5% | -$7.57K | ﹤0.01% | 2036 |
|
|
2017
Q3 | $144K | Buy |
4,856
+329
| +7% | +$9.47K | ﹤0.01% | 2376 |
|
|
2017
Q2 | $131K | Sell |
4,527
-2,653
| -37% | -$68.3K | ﹤0.01% | 2488 |
|
|
2017
Q1 | $168K | Hold |
7,180
| – | – | ﹤0.01% | 2362 |
|
|
2016
Q4 | $152K | Sell |
7,180
-323
| -4% | -$7.06K | ﹤0.01% | 2490 |
|
|
2016
Q3 | $170K | Sell |
7,503
-361
| -5% | -$8.27K | ﹤0.01% | 2434 |
|
|
2016
Q2 | $179K | Sell |
7,864
-458
| -6% | -$12.2K | ﹤0.01% | 2396 |
|
|
2016
Q1 | $233K | Hold |
8,322
| – | – | ﹤0.01% | 2080 |
|
|
2015
Q4 | $202K | Buy |
8,322
+223
| +3% | +$4.63K | ﹤0.01% | 2264 |
|
|
2015
Q3 | $133K | Hold |
8,099
| – | – | ﹤0.01% | 2525 |
|
|
2015
Q2 | $165K | Buy |
8,099
+338
| +4% | +$6.83K | ﹤0.01% | 2497 |
|
|
2015
Q1 | $143K | Hold |
7,761
| – | – | ﹤0.01% | 2156 |
|
|
2014
Q4 | $152K | Buy |
7,761
+207
| +3% | +$3.98K | ﹤0.01% | 2550 |
|
|
2014
Q3 | $140K | Sell |
7,554
-57
| -0.7% | -$1.22K | ﹤0.01% | 2565 |
|
|
2014
Q2 | $185K | Buy |
7,611
+83
| +1% | +$1.8K | ﹤0.01% | 2565 |
|
|
2014
Q1 | $172K | Hold |
7,528
| – | – | ﹤0.01% | 2556 |
|
|
2013
Q4 | $149K | Hold |
7,528
| – | – | ﹤0.01% | 2625 |
|
|
2013
Q3 | $155K | Sell |
7,528
-101
| -1% | -$1.93K | ﹤0.01% | 2602 |
|
|
2013
Q2 | $123K | Buy |
+7,629
| New | +$132K | ﹤0.01% | 2634 |
|
Other funds holding BRKR
PCA
Metropolitan Life Insurance Company (MetLife)'s BRKR Position: Q1 2022 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Bruker (BRKR) in Q1 2022, closing a stake of 22,960 shares — an estimated $1.93M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in BRKR in Q2 2013 and held it in 35 quarters. The position peaked at $1.93M in Q4 2021. 311 funds tracked by Wall St. Rank hold BRKR as of Q1 2022.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Bruker position as of Q1 2022 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 22,960 Bruker shares in Q1 2022, an estimated $1.93M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Bruker in Q2 2013 and held it in 35 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Bruker position peaked at $1.93M in Q4 2021.
- 311 funds tracked by Wall St. Rank held Bruker as of Q1 2022.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.